Výsledky vyhledávání - "S. Aarrestad"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

EXPOSURE TO SPECIFIC TUMOR NECROSIS FACTOR INHIBITORS AND RISK OF DEMYELINATING AND INFLAMMATORY NEUROPATHY IN PATIENTS WITH INFLAMMATORY ARTHRITIS. A COLLABORATIVE OBSERVATIONAL STUDY ACROSS FIVE NORDIC RHEUMATOLOGY REGISTERS

Autor: Delcoigne, B., Kopp, T. I., Arkema, E., Hellgren, K., Provan, S. Aarrestad, Relas, H., Aaltonen, K., Trokovic, N., Gudbjornsson, B., Gröndal, G., Kristianslund, E., Dreyer, L., Askling, J.

Publikováno v: Delcoigne, B, Kopp, T I, Arkema, E, Hellgren, K, Provan, S A, Relas, H, Aaltonen, K, Trokovic, N, Gudbjornsson, B, Gröndal, G, Kristianslund, E, Dreyer, L & Askling, J 2022, ' EXPOSURE TO SPECIFIC TUMOR NECROSIS FACTOR INHIBITORS AND RISK OF DEMYELINATING AND INFLAMMATORY NEUROPATHY IN PATIENTS WITH INFLAMMATORY ARTHRITIS. A COLLABORATIVE OBSERVATIONAL STUDY ACROSS FIVE NORDIC RHEUMATOLOGY REGISTERS ', Annals of the Rheumatic Diseases, vol. 81, no. Suppl. 1, OP0060 , pp. 41 . https://doi.org/10.1136/annrheumdis-2022-eular.2866

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::dcbfecff9a60be67813db9d6f1440ed9
https://vbn.aau.dk/da/publications/35c775c1-ef04-4cb7-88d1-457ee0cbfdc6

Zobrazit plný text záznamu

POS0932 UPTAKE OF NEWER BIOLOGIC AND TARGETED SYNTHETIC DMARDs IN PSORIATIC ARTHRITIS, RESULTS FROM FOUR NORDIC BIOLOGIC REGISTRIES

Autor: B. Glintborg, D. DI Giuseppe, J. K. Wallman, D. Nordström, B. Gudbjornsson, M. L. Hetland, J. Askling, G. Gröndal, T. Sokka-Isler, S. Aarrestad Provan, U. Lindström

Publikováno v: Annals of the Rheumatic Diseases. 81:766-767

BackgroundThe treatment landscape in psoriatic arthritis (PsA) is changing, including newer biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) with different modes of action becoming available. However, the most effect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0c80f67afc41bdda1d7f17a2ec657c59
https://doi.org/10.1136/annrheumdis-2022-eular.488

Zobrazit plný text záznamu

OP0176 THE PERSISTENCE OF ANTI-SPIKE ANTIBODIES FOLLOWING TWO SARS-CoV-2 VACCINES IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES USING IMMUNOSUPPRESSIVE THERAPY, COMPARED TO HEALTHY CONTROLS

Autor: I. Egeland Christensen, I. Jyssum, A. T. Tveter, J. Sexton, T. T. Tran, S. Mjaaland, G. B. Kro, T. K. Kvien, D. Worren, J. Jahnsen, L. A. Munthe, E. Haavardsholm, J. T. Vaage, G. Grodeland, F. Lund-Johansen, K. K. Jørgensen, S. W. Syversen, G. L. Goll, S. Aarrestad Provan

Publikováno v: Annals of the Rheumatic Diseases. 81:116-117

BackgroundLimited data is available regarding long-term effectiveness of SARS-CoV-2 vaccines in patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressive therapy. Whether the persistence of vaccine-induced humoral immunity agai

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c27f5be5eca635a6c6c553dbe8c63234
https://doi.org/10.1136/annrheumdis-2022-eular.2054

Zobrazit plný text záznamu

BIOLOGIC REFRACTORY DISEASE IN AXIAL SPONDYLOARTHRITIS - DEFINITION, PREVALENCE AND PATIENT CHARACTERISTICS. A COLLABORATION BETWEEN FIVE NORDIC BIOLOGIC REGISTRIES

Autor: Di Giuseppe, D, Lindström, U, Aaltonen, K, Relas, H, Provan, S Aarrestad, Gudbjornsson, B, Hetland, M L, Askling, J, Jørgensen, T Schjødt, Dreyer, L, Nordström, D, Michelsen, B, Geirsson, A J, Jacobsson, L T H, Glintborg, B

Publikováno v: Di Giuseppe, D, Lindström, U, Aaltonen, K, Relas, H, Provan, S A, Gudbjornsson, B, Hetland, M L, Askling, J, Jørgensen, T S, Dreyer, L, Nordström, D, Michelsen, B, Geirsson, A J, Jacobsson, L T H & Glintborg, B 2021, ' BIOLOGIC REFRACTORY DISEASE IN AXIAL SPONDYLOARTHRITIS-DEFINITION, PREVALENCE AND PATIENT CHARACTERISTICS. A COLLABORATION BETWEEN FIVE NORDIC BIOLOGIC REGISTRIES ', Annals of the Rheumatic Diseases, vol. 80, no. 1, OP0140, pp. 82-83 . https://doi.org/10.1136/annrheumdis-2021-eular.630

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7533806cc21381f2beafd098bbd06d05
https://vbn.aau.dk/da/publications/15fcfbf0-e0b1-44e3-b53d-8b6e0007c603

Zobrazit plný text záznamu

OP0060 EXPOSURE TO SPECIFIC TUMOR NECROSIS FACTOR INHIBITORS AND RISK OF DEMYELINATING AND INFLAMMATORY NEUROPATHY IN PATIENTS WITH INFLAMMATORY ARTHRITIS. A COLLABORATIVE OBSERVATIONAL STUDY ACROSS FIVE NORDIC RHEUMATOLOGY REGISTERS

Autor: B. Delcoigne, T. I. Kopp, E. Arkema, K. Hellgren, S. Aarrestad Provan, H. Relas, K. Aaltonen, N. Trokovic, B. Gudbjornsson, G. Gröndal, E. Kristianslund, L. Dreyer, J. Askling

Publikováno v: Annals of the Rheumatic Diseases. 81:41-41

BackgroundThough rare, studies have reported increased risk of neurological events including demyelinating disease of CNS (DML), multiple sclerosis (MS), and inflammatory neuropathy (INP) in patients with inflammatory joint disease treated with tumor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2aa8cb399f17a1ea43d0c885a21e8522
https://doi.org/10.1136/annrheumdis-2022-eular.2866

Zobrazit plný text záznamu

POS0568 HOW DOES INSTANTANEOUS RA DISEASE ACTIVITY AFFECT THE SHORT-TERM RISK OF ACUTE CORONARY SYNDROME? – A REGISTER-BASED STUDY

Autor: B. Delcoigne, S. Aarrestad Provan, E. Kristianslund, J. Askling, L. Ljung

Publikováno v: Annals of the Rheumatic Diseases. 81:549.2-550

BackgroundRheumatoid arthritis (RA) patients have a reduced life expectancy, with cardiovascular disease (CVD) being the most frequent cause of death. The mechanisms behind the increased CVD morbidity and mortality in RA are not fully understood. Sys

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c6acdc1b8093c92eb7d1c802a39ede45
https://doi.org/10.1136/annrheumdis-2022-eular.4373

Zobrazit plný text záznamu

OP0192 SEROLOGICAL RESPONSE AND SAFETY OF A THREE-DOSE SARS-CoV-2 VACCINATION STRATEGY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY

Publikováno v: Annals of the Rheumatic Diseases. 81:127.1-128

BackgroundPatients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressive therapy have an inadequate serologic response following two-dose SARS-CoV-2 vaccination, and a standard vaccination strategy of three doses for this patient gr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1e4685e941b749bd57aafa06cbb68608
https://doi.org/10.1136/annrheumdis-2022-eular.1230

Zobrazit plný text záznamu

OP0222 THE INCIDENCE OF INTERSTITIAL LUNG DISEASE IN PSORIATIC ARTHRITIS COMPARED TO RHEUMATOID ARTHRITIS. DATA FROM OVER 89 000 BDMARD TREATMENT COURSES DERIVED FROM FIVE NORDIC REGISTERS

Autor: Eirik Kristianslund, Lotta Ljung, S. Aarrestad Provan, Bjorn Gudbjornsson, D. Di Giuseppe, Heikki Relas, G. B. Reynisdóttir, Brigitte Michelsen, M.L. Hetland, T. Jonmundsson, Johan Askling, T.K. Kvien, Kalle Aaltonen, Dan Nordström, B. Glintborg

Publikováno v: Annals of the Rheumatic Diseases. 80:133-134

Background:Interstitial lung disease (ILD) is an established extra-articular manifestation of rheumatoid arthritis (RA). Few studies have investigated the prevalence of ILD in patients with psoriatic arthritis (PsA). Methotrexate (MTX) is frequently

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0d6e5f39073e6ad85e767bb6dfa4b08c
https://doi.org/10.1136/annrheumdis-2021-eular.2955

Zobrazit plný text záznamu

OP0140 BIOLOGIC REFRACTORY DISEASE IN AXIAL SPONDYLOARTHRITIS - DEFINITION, PREVALENCE AND PATIENT CHARACTERISTICS. A COLLABORATION BETWEEN FIVE NORDIC BIOLOGIC REGISTRIES

Autor: Dan Nordström, Johan Askling, Lene Dreyer, T. Schjødt Jørgensen, Merete Lund Hetland, D. Di Giuseppe, Heikki Relas, Bjorn Gudbjornsson, Bente Glintborg, Ulf Lindström, S. Aarrestad Provan, Brigitte Michelsen, L. T. H. Jacobsson, Kalle Aaltonen, Arni Jon Geirsson

Publikováno v: Annals of the Rheumatic Diseases. 80:82-83

Background:In clinical practice, some patients with axial spondyloarthritis (axSpA) fail several consecutive biological treatments (bDMARDs). How this group of ”refractory” patients should best be defined, how common they are, and what their char

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca3f54e4f6e85d8be92109f4f467c409
https://doi.org/10.1136/annrheumdis-2021-eular.630

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání